Skip to main content

ABBV-1882

ABBV-1882 is a combination of ABBV-181 (anti-PD1) and ABBV-382 (anti-a4b7 mAb) being investigated for a functional cure to HIV. 

Type of Molecule

Biologic

Target

anti-PD1 and anti-a4b7 mAb

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted)
HIV n/a
Phase 1